PlainRecalls
FDA Drug Moderate Class II Terminated

Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.

Reported: October 15, 2025 Initiated: September 22, 2025 #D-0003-2026

Product Description

Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.

Reason for Recall

Lack of assurance of sterility.

Details

Recalling Firm
RC Outsourcing, LLC
Units Affected
2,669 syringes
Distribution
Nationwide in the US
Location
Lowellville, OH

Frequently Asked Questions

What product was recalled?
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.. Recalled by RC Outsourcing, LLC. Units affected: 2,669 syringes.
Why was this product recalled?
Lack of assurance of sterility.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 15, 2025. Severity: Moderate. Recall number: D-0003-2026.